Ignite Creation Date:
2024-05-05 @ 5:20 PM
Last Modification Date:
2024-10-26 @ 9:30 AM
Study NCT ID:
NCT00435227
Status:
TERMINATED
Last Update Posted:
2021-08-17
First Post:
2007-02-13
Brief Title:
A Study to Evaluate a Single Intramuscular Dose of Motavizumab to Treat Children With Respiratory Syncytial Virus RSV Illness
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Organization Data
Organization:
MedImmune LLC
Class:
INDUSTRY
Study ID:
MI-CP146
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
MedImmune LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None